These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 8507075)

  • 1. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin.
    Man MQ; Feingold KR; Elias PM
    Arch Dermatol; 1993 Jun; 129(6):728-38. PubMed ID: 8507075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regulation of the epidermal permeability barrier by lipids and hyperproliferation].
    Proksch E
    Hautarzt; 1992 Jun; 43(6):331-8. PubMed ID: 1628964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model.
    Ghadially R; Brown BE; Sequeira-Martin SM; Feingold KR; Elias PM
    J Clin Invest; 1995 May; 95(5):2281-90. PubMed ID: 7738193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty acids are required for epidermal permeability barrier function.
    Mao-Qiang M; Elias PM; Feingold KR
    J Clin Invest; 1993 Aug; 92(2):791-8. PubMed ID: 8102380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin.
    Zettersten EM; Ghadially R; Feingold KR; Crumrine D; Elias PM
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):403-8. PubMed ID: 9308554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulation of epidermal lipid synthesis by permeability barrier requirements.
    Feingold KR
    Crit Rev Ther Drug Carrier Syst; 1991; 8(3):193-210. PubMed ID: 1954650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS; Fluhr JW; Man MQ; Fowler AJ; Hachem JP; Crumrine D; Ahn SK; Brown BE; Elias PM; Feingold KR
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray diffraction analysis of isolated skin lipids: reconstitution of intercellular lipid domains.
    McIntosh TJ; Stewart ME; Downing DT
    Biochemistry; 1996 Mar; 35(12):3649-53. PubMed ID: 8619983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction.
    Mao-Qiang M; Brown BE; Wu-Pong S; Feingold KR; Elias PM
    Arch Dermatol; 1995 Jul; 131(7):809-16. PubMed ID: 7611797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
    Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM
    J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human stratum corneum lipid organization as observed by atomic force microscopy on Langmuir-Blodgett films.
    Norlén L; Gil IP; Simonsen A; Descouts P
    J Struct Biol; 2007 Jun; 158(3):386-400. PubMed ID: 17287132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid and neutral sphingomyelinase, ceramide synthase, and acid ceramidase activities in cutaneous aging.
    Jensen JM; Förl M; Winoto-Morbach S; Seite S; Schunck M; Proksch E; Schütze S
    Exp Dermatol; 2005 Aug; 14(8):609-18. PubMed ID: 16026583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of membrane raft formation: fatty acid domains in stratum corneum lipid models.
    Moore DJ; Snyder RG; Rerek ME; Mendelsohn R
    J Phys Chem B; 2006 Feb; 110(5):2378-86. PubMed ID: 16471828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis.
    Harris IR; Farrell AM; Grunfeld C; Holleran WM; Elias PM; Feingold KR
    J Invest Dermatol; 1997 Dec; 109(6):783-7. PubMed ID: 9406821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function.
    Behne M; Uchida Y; Seki T; de Montellano PO; Elias PM; Holleran WM
    J Invest Dermatol; 2000 Jan; 114(1):185-92. PubMed ID: 10620136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microstructure of the stratum corneum lipid barrier: mid-infrared spectroscopic studies of hydrated ceramide:palmitic acid:cholesterol model systems.
    Garidel P; Fölting B; Schaller I; Kerth A
    Biophys Chem; 2010 Aug; 150(1-3):144-56. PubMed ID: 20457485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary glucosylceramide improves skin barrier function in hairless mice.
    Tsuji K; Mitsutake S; Ishikawa J; Takagi Y; Akiyama M; Shimizu H; Tomiyama T; Igarashi Y
    J Dermatol Sci; 2006 Nov; 44(2):101-7. PubMed ID: 17000082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal lipids.
    Wertz PW
    Semin Dermatol; 1992 Jun; 11(2):106-13. PubMed ID: 1498013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.
    Holleran WM; Man MQ; Gao WN; Menon GK; Elias PM; Feingold KR
    J Clin Invest; 1991 Oct; 88(4):1338-45. PubMed ID: 1918384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of physiological lipid mixtures for barrier repair.
    Man MQ M; Feingold KR; Thornfeldt CR; Elias PM
    J Invest Dermatol; 1996 May; 106(5):1096-101. PubMed ID: 8618046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.